# FDA 483 - Gland Pharma Limited, Units I+II Pashamylaram Site - August 02, 2024

Source: https://www.globalkeysolutions.net/records/483/gland-pharma-limited-units-iii-pashamylaram-site/aed20ec2-46aa-441a-81bc-f5356b9f897b

> FDA 483 for Gland Pharma Limited, Units I+II Pashamylaram Site on August 02, 2024. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Gland Pharma Limited, Units I+II Pashamylaram Site
- Inspection Date: 2024-08-02
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [483 - Unknown Date](https://www.globalkeysolutions.net/records/483/gland-pharma-limited-units-iii-pashamylaram-site/5f036c41-b2e6-4bdc-b9ac-af5430590125)

## Related Officers

- [Consumer Safety Officer](https://www.globalkeysolutions.net/people/jeffrey-p-raimondi/7576ca4e-d9e8-4015-9ae6-9498e76058d3)
- [Investigator](https://www.globalkeysolutions.net/people/roger-f-zabinski/87e05838-f8b5-489a-8db7-6669e68a2c2e)

Company: https://www.globalkeysolutions.net/companies/gland-pharma-limited-units-iii-pashamylaram-site/a7dffca3-c5cc-4802-9cab-54995e7133ca

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c